Albert Liclican

1.4k total citations
14 papers, 483 citations indexed

About

Albert Liclican is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, Albert Liclican has authored 14 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 8 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Albert Liclican's work include Synthesis and biological activity (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Albert Liclican is often cited by papers focused on Synthesis and biological activity (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Albert Liclican collaborates with scholars based in United States and United Kingdom. Albert Liclican's co-authors include Brian E. Schultz, Weimei Xing, Ruth Wang, Melanie Wong, Giuseppe A. Papalia, Armando G. Villaseñor, Roman Sakowicz, Katherine M. Brendza, Latesh Lad and David Koditek and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Albert Liclican

14 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Liclican United States	10	254	136	112	95	77	14	483
Leanne Cartee United States	14	357 1.4×	82 0.6×	51 0.5×	94 1.0×	35 0.5×	27	646
Ruo W. Steensma United States	8	313 1.2×	148 1.1×	38 0.3×	118 1.2×	62 0.8×	9	740
Hieu Lam United States	6	178 0.7×	99 0.7×	78 0.7×	22 0.2×	29 0.4×	6	507
Daniel P. Larson United States	10	222 0.9×	141 1.0×	27 0.2×	68 0.7×	23 0.3×	23	525
Nilesh Zaware United States	12	463 1.8×	141 1.0×	20 0.2×	35 0.4×	27 0.4×	19	625
Oliver Kraemer Germany	7	442 1.7×	189 1.4×	49 0.4×	30 0.3×	32 0.4×	9	912
Michael Fitzgerald United States	11	600 2.4×	254 1.9×	57 0.5×	26 0.3×	44 0.6×	17	1.0k
Sheri Rogers United States	4	292 1.1×	102 0.8×	12 0.1×	104 1.1×	18 0.2×	7	477
Anthony P. Schiavone United States	6	220 0.9×	20 0.1×	61 0.5×	27 0.3×	30 0.4×	6	376
Sanjeev Redkar United States	14	673 2.6×	121 0.9×	76 0.7×	24 0.3×	368 4.8×	29	1.0k

Countries citing papers authored by Albert Liclican

Since Specialization

Citations

This map shows the geographic impact of Albert Liclican's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Liclican with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Liclican more than expected).

Fields of papers citing papers by Albert Liclican

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Liclican. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Liclican. The network helps show where Albert Liclican may publish in the future.

Co-authorship network of co-authors of Albert Liclican

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Liclican. A scholar is included among the top collaborators of Albert Liclican based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Liclican. Albert Liclican is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Liclican, Albert, Weimei Xing, Gregg Czerwieniec, et al.. (2020). Biochemical characterization of tirabrutinib and other irreversible inhibitors of Bruton's tyrosine kinase reveals differences in on - and off - target inhibition. Biochimica et Biophysica Acta (BBA) - General Subjects. 1864(4). 129531–129531. 74 indexed citations

Yu, Helen, Hoa Truong, Scott A. Mitchell, et al.. (2018). Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement. SLAS DISCOVERY. 23(9). 919–929. 13 indexed citations

Appleby, T.C., Andrew E. Greenstein, Magdeleine Hung, et al.. (2017). Biochemical characterization and structure determination of a potent, selective antibody inhibitor of human MMP9. Journal of Biological Chemistry. 292(16). 6810–6820. 76 indexed citations

Liclican, Albert, Weimei Xing, Ting Wang, et al.. (2016). Biochemical Characterization of GS-4059 As a Potent and Selective Covalent Irreversible Inhibitor of Bruton's Tyrosine Kinase. Blood. 128(22). 1594–1594. 2 indexed citations

Somoza, John R., David Koditek, Armando G. Villaseñor, et al.. (2015). Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ. Journal of Biological Chemistry. 290(13). 8439–8446. 119 indexed citations

Tan, Xuefei, Richland Tester, Gregory R. Luedtke, et al.. (2010). Design and synthesis of piperazine-indole p38α MAP kinase inhibitors with improved pharmacokinetic profiles. Bioorganic & Medicinal Chemistry Letters. 20(3). 828–831. 12 indexed citations

Tester, Richland, Xuefei Tan, Gregory R. Luedtke, et al.. (2010). Amide-based inhibitors of p38α MAP kinase. Part 2: Design, synthesis and SAR of potent N-pyrimidyl amides. Bioorganic & Medicinal Chemistry Letters. 20(8). 2560–2563. 2 indexed citations

Mavunkel, Babu, John Perumattam, Xuefei Tan, et al.. (2009). Piperidine-based heterocyclic oxalyl amides as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1059–1062. 21 indexed citations

Kirschberg, Thorsten, M. Balakrishnan, Neil Squires, et al.. (2009). RNase H Active Site Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Design, Biochemical Activity, and Structural Information. Journal of Medicinal Chemistry. 52(19). 5781–5784. 86 indexed citations

10.

Levy, Daniel E., Qing Lu, Zheng Chen, et al.. (2008). Aryl–indolyl maleimides as inhibitors of CaMKIIδ. Part 1: SAR of the aryl region. Bioorganic & Medicinal Chemistry Letters. 18(7). 2390–2394. 14 indexed citations

11.

Levy, Daniel E., Qing Lu, Zheng Chen, et al.. (2008). Aryl-indolyl maleimides as inhibitors of CaMKIIδ. Part 2: SAR of the amine tether. Bioorganic & Medicinal Chemistry Letters. 18(7). 2395–2398. 9 indexed citations

12.

Mavunkel, Babu, Yongjin Xu, Bindu Goyal, et al.. (2008). Pyrimidine-based inhibitors of CaMKIIδ. Bioorganic & Medicinal Chemistry Letters. 18(7). 2404–2408. 13 indexed citations

13.

Chen, Zheng, John Perumattam, Yongjin Xu, et al.. (2008). Aryl–indolyl maleimides as inhibitors of CaMKIIδ. Part 3: Importance of the indole orientation. Bioorganic & Medicinal Chemistry Letters. 18(7). 2399–2403. 6 indexed citations

14.

Kirschberg, Thorsten, M. Balakrishnan, Wei Huang, et al.. (2007). Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—Structure–activity relationships and crystallographic analysis. Bioorganic & Medicinal Chemistry Letters. 18(3). 1131–1134. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact